We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plasmon | LSE:PLM | London | Ordinary Share | GB0006906381 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.33 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 8138C Plasmon PLC 05 September 2008 Plasmon plc Update and announcement of approach On 8 August 2008 Plasmon ("Plasmon" or the "Company") issued its first interim management statement for the year ending 31 March 2009 and an update on trading. In this announcement, Plasmon stated that the overall strategy outlined in February 2008 is being executed, with several key elements on track or ahead of plan. However, the sales performance in the first quarter was disappointing, and approximately 20% below the Board's expectations. Consequently, the Board reduced its overall sales expectations for the year and initiated a further programme of cost reduction and financial restructuring. The Board also announced that in light of this the Company required additional financing and had engaged in a process to secure this within an appropriate timescale. Since 8 August, the Board has continued its marketing exercise, primarily with US investors, with a view to securing additional debt or equity capital. The Company has not received commitments from potential investors that the Directors consider immediately necessary to fund the business and its ongoing working capital requirements. However, the Company confirms it has now received an approach from a US-based technology private equity firm at an investment value of some $25 million and at a net price payable to shareholders of not more than 0.25 pence in cash per share at today's US dollar exchange rate, and confirms that it is currently in preliminary discussions which may or may not lead to an offer for the entire issued and to be issued share capital of the Company. The investment value includes a significant injection of new funds to enable a major restructuring to be completed. Given the absence of other financing options, and given the Company's financial position, the Board has concluded that such a sale is the best viable option for the Company. There can be no certainty that any offer will be made nor as to the terms of any such offer. Pursuant to Note 7 to Rule 2.4 the Company notes that this announcement is made without the agreement or approval of the potential offeror. A further announcement will be made when appropriate. Relevant Securities in Issue In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Plasmon confirms that as of close of business on 4 September 2008 Plasmon has 220,756,276 ordinary shares of 5p each in issue and admitted to trading on the London Stock Exchange under the UK ISIN code GB0006906381. Dealing Disclosure Requirements Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Plasmon, all dealings in any relevant securities of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Plasmon, they will be deemed to be a single person for the purpose of Rule 8.3. Under provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Plasmon by the potential offeror, Plasmon or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction. A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the prices of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue or any option in respect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel. This information is provided by RNS The company news service from the London Stock Exchange END MSCGUGDCLSGGGIU
1 Year Plasmon plc Chart |
1 Month Plasmon plc Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions